Latest Stock Market News

S&P Dow Jones Indices has announced its September 2025 quarterly rebalance, with significant additions and removals across multiple ASX indices set to take effect before market open on September 22.

CLINUVEL Pharmaceuticals is preparing to elevate its American Depository Receipt program to a Nasdaq Level II listing by the end of 2025, aiming to enhance visibility and trading access in the U.S. without altering its primary ASX listing.

London City Equities reported a $11.3 million capital gain primarily from trimming its Fiducian Group stake, reversing prior losses to post a $500,000 profit and declaring a 2.5 cent fully franked dividend including a special payout.

Advanced Health Intelligence has been formally delisted from NASDAQ due to shareholder equity deficiencies but is actively pursuing ASX reinstatement as a critical step toward regaining its dual-listing status.

Micro-X Limited's trading suspension has been lifted following its announcement of an equity raising, signaling renewed market activity for the medical technology firm.